ArticleResearch square2025
Sex differences in antibody responses to influenza A/H3N2 across the life course.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Sex differences in both innate and adaptive immunity are increasingly recognized as shaping responses to a range of pathogens. For antigenically variable pathogens that infect people many times over their lifetime, like influenza, sex differences may accumulate or be obscured by the interplay of immunity derived from each infection and future risk. However, sex-specific lifetime trajectories of influenza immunity are poorly characterized. Here, we analyzed hemagglutination inhibition antibody titers to multiple strains of influenza A/H3N2, measured in individuals spanning a wide age range to disentangle strain-specific and cross-reactive antibody responses by sex. To account for potential differences in exposure, we separately analyzed antibody titers to: (1) viruses circulating during an individual's lifetime, and (2) viruses isolated before birth (pre-birth) or after sampling, with responses to the latter interpreted as exclusively cross-reactive, given the absence of possible exposure to these strains. We found that females aged 15 to 40 generally have higher antibody titers than males against pre-birth and post-sampling strains, consistent with greater cross-reactivity. Conversely, older males have stronger responses to strains that they could have encountered during their lives, suggesting that they mount stronger responses upon infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.